Coherus Oncology, Inc. vs Acumen Pharmaceuticals, Inc., risk disclosures compared

4topics both disclose

7only Coherus Oncology, Inc.

0only Acumen Pharmaceuticals, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Coherus Oncology, Inc.	Acumen Pharmaceuticals, Inc.
Internal Control	9	2
Restatement	8	3
Enforcement Action	3	2
Material Weakness	2	1

Only Coherus Oncology, Inc.

Topic	Filings
Business Continuity	27
Ransomware	9
Data Breach	5
Consent Order	3
Regulatory Investigation	2
Records Retention	1
Regulatory Reporting	1

Only Acumen Pharmaceuticals, Inc.

Nothing.

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Coherus Oncology, Inc. · Acumen Pharmaceuticals, Inc. · All companies